These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28602013)

  • 1. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
    Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM
    Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
    Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior limbic keratoconjunctivitis causing chronic ocular irritation in a child.
    Gupta A; Morini C; Sachdeva V; Kekunnaya R
    J AAPOS; 2012 Dec; 16(6):579-81. PubMed ID: 23158547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
    Takahashi Y; Ichinose A; Kakizaki H
    Am J Ophthalmol; 2014 Apr; 157(4):807-812.e2. PubMed ID: 24412123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D; Khan M; Gul A; Alam R
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
    Sahin A; Bozkurt B; Irkec M
    Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
    Santos CI; Huang AJ; Abelson MB; Foster CS; Friedlaender M; McCulley JP
    Am J Ophthalmol; 1994 Apr; 117(4):488-97. PubMed ID: 8154531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
    Gündüz K; Uçakhan O; Budak K; Eryilmaz T; Ozkan M
    Ophthalmic Res; 1996; 28(2):80-7. PubMed ID: 8792357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment.
    Kymionis GD; Klados NE; Kontadakis GA; Mikropoulos DG
    Cornea; 2013 Nov; 32(11):1499-501. PubMed ID: 23770977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Severity Classification using Automated Conjunctival Hyperemia Analysis Software in Patients with Superior Limbic Keratoconjunctivitis.
    Kurita J; Shoji J; Inada N; Yoneda T; Sumi T; Kobayashi M; Hoshikawa Y; Fukushima A; Yamagami S
    Curr Eye Res; 2018 Jun; 43(6):679-682. PubMed ID: 29336627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lodoxamide as adjuvant therapy in patients with dry eye.
    Petricek I; Pokupec R; Petricek G; Salopek-Rabatić J
    Coll Antropol; 2001; 25 Suppl():149-52. PubMed ID: 11817007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketotifen fumarate treatment of superior limbic keratoconjunctivitis.
    Udell IJ; Guidera AC; Madani-Becker J
    Cornea; 2002 Nov; 21(8):778-80. PubMed ID: 12410035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis.
    Schoch C
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):153-9. PubMed ID: 12804060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.
    Perry HD; Doshi-Carnevale S; Donnenfeld ED; Kornstein HS
    Ophthalmology; 2003 Aug; 110(8):1578-81. PubMed ID: 12917176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM
    Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival resection combined with tenon layer excision and the involvement of mast cells in superior limbic keratoconjunctivitis.
    Sun YC; Hsiao CH; Chen WL; Wang IJ; Hou YC; Hu FR
    Am J Ophthalmol; 2008 Mar; 145(3):445-452. PubMed ID: 18201682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S
    Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.